Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer
出版年份 2016 全文链接
标题
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer
作者
关键词
Colorectal cancer, FF (fresh-frozen), FFPE (formalin-fixed, Paraffin embedded), Microarray, NanoString, RAS pathway signature, RNASeq
出版物
BMC Medical Genomics
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-10-19
DOI
10.1186/s12920-016-0225-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST)
- (2015) Annalisa Astolfi et al. BMC GENOMICS
- Evaluating Robustness and Sensitivity of the NanoString Technologies nCounter Platform to Enable Multiplexed Gene Expression Analysis of Clinical Samples
- (2015) M. H. Veldman-Jones et al. CANCER RESEARCH
- A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome
- (2015) M. J. Schell et al. CLINICAL CANCER RESEARCH
- New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?
- (2015) Giuseppe Bronte et al. Oncotarget
- A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of Thresholds
- (2015) Dana A. M. Mustafa et al. PLoS One
- Reproducible, Quantitative, and Flexible Molecular Subtyping of Clinical DLBCL Samples Using the NanoString nCounter System
- (2014) M. H. Veldman-Jones et al. CLINICAL CANCER RESEARCH
- Modeling RAS Phenotype in Colorectal Cancer Uncovers Novel Molecular Traits of RAS Dependency and Improves Prediction of Response to Targeted Agents in Patients
- (2013) J. Guinney et al. CLINICAL CANCER RESEARCH
- KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs and beyond
- (2013) Umberto Malapelle et al. JOURNAL OF CLINICAL PATHOLOGY
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues
- (2012) Gregory P. Sfakianos et al. GYNECOLOGIC ONCOLOGY
- Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
- (2012) Cole Trapnell et al. Nature Protocols
- A Reliable Method for the Selection of Exploitable Melanoma Archival Paraffin Embedded Tissues for Transcript Biomarker Profiling
- (2012) Celeste Lebbe et al. PLoS One
- MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF
- (2012) Neda Mosakhani et al. Cancer Genetics
- mRNA transcript quantification in archival samples using multiplexed, color-coded probes
- (2011) Patricia P Reis et al. BMC BIOTECHNOLOGY
- Implementing Personalized Medicine in a Cancer Center
- (2011) David A. Fenstermacher et al. CANCER JOURNAL
- Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells
- (2011) P. C. Hollenhorst et al. GENES & DEVELOPMENT
- Gene Expression Profiles from Formalin Fixed Paraffin Embedded Breast Cancer Tissue Are Largely Comparable to Fresh Frozen Matched Tissue
- (2011) Lorenza Mittempergher et al. PLoS One
- Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues
- (2010) Iker Sánchez-Navarro* et al. BIOTECHNIQUES
- A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors
- (2010) Andrey Loboda et al. BMC Medical Genomics
- Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
- (2010) J. R. Dry et al. CANCER RESEARCH
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Differential expression analysis for sequence count data
- (2010) Simon Anders et al. GENOME BIOLOGY
- Filtering for increased power for microarray data analysis
- (2009) Amber J Hackstadt et al. BMC BIOINFORMATICS
- KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
- (2009) F Loupakis et al. BRITISH JOURNAL OF CANCER
- Predictive Biomarkers: Identification and Verification
- (2009) Timothy J. Yeatman JOURNAL OF CLINICAL ONCOLOGY
- Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
- (2009) Pierre Laurent-Puig et al. JOURNAL OF CLINICAL ONCOLOGY
- TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation
- (2008) Michael D Oberst et al. BMC CANCER
- RNA expression analysis from formalin fixed paraffin embedded tissues
- (2008) Susan M. Farragher et al. HISTOCHEMISTRY AND CELL BIOLOGY
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started